Abstract:Key PointsInnate lymphoid cells (ILCs) are newly identified members of the lymphoid lineage with emerging roles in mediating immune responses and in regulating tissue homeostasis and inflammation.The existence of different ILC populations that can rapidly secrete immunoregulatory cytokines suggests that these cells may have evolved to provide immunity to infections. Indeed, it is notable that ILC subsets seem to be particularly prevalent at mucosal surfaces, which are constantly exposed to infectious agents in the external environment.The group 1 ILC lineage comprises ILCs such as natural killer (NK) cells that produce type 1 cytokines, notably interferon-γ and tumour necrosis factor. Other group 1 ILCs have been reported, mainly in vitro, and their physiological roles remain to be defined.The group 2 ILC population comprises ILC2s, which express interleukin-5 (IL-5) and IL-13 and require GATA-binding protein 3 (GATA3) and retinoic acid receptor-related orphan receptor-α (RORα) for their development. They have crucial roles in protective type 2 immunity to helminth infection. Furthermore, although T helper 2 cells are a major source of type 2 cytokines during allergic asthma, ILC2s also contribute to disease pathology.ILC3s were first defined as intestinal lymphoid cells that express the NK cell activating receptor NKp46, but otherwise bear little functional resemblance to conventional NK cells, and require RORγ for their development. They express IL-17A and IL-22.Recent studies have also implicated ILC3s in the development of inflammatory bowel disease. Studies in Rag2−/− mice demonstrated that, in the early phase of Citrobacter rodentium infection, IL-22 is produced from an innate cell source.Lymphoid tissue-inducer (LTi) cells are an ILC subset that appears to be closely related to ILC3s, but their exact relationship remains controversial. Together, LTi cells and ILC3s have been classified as group 3 ILCs.

Type 1 immunity enables neonatal thymic ILC1 production

A Protocol to Develop T Helper and Treg Cells in Vivo

Type 1 Innate Lymphoid Cells Limit the Antitumoral Immune Response

Cytotoxic granzyme C–expressing ILC1s contribute to antitumor immunity and neonatal autoimmunity

Innate lymphoid cells — how did we miss them?

TL1A and IL-18 synergy promotes GM-CSF-dependent thymic granulopoiesis in mice

Preferential perinatal thymic generation of skin-homing CCR10+ NK1.1+ innate lymphocytes for establishment of skin homeostasis

Group 1 ILCs: Heterogeneity, plasticity, and transcriptional regulation

Type I interferon induced during chronic viral infection favors B-cell development in the thymus

Natural killer cells and type 1 innate lymphoid cells in cancer

Single-cell RNA-sequencing identifies the developmental trajectory of C-Myc-dependent NK1.1− T-bet+ intraepithelial lymphocyte precursors

Tuft cells and fibroblasts promote thymus regeneration through ILC2-mediated type 2 immune response

Innate Lymphoid Cells and Inflammatory Bowel Disease

Parallel origins and functions of T cells and ILCs

Group 2 Innate Lymphoid Cells Exhibit Tissue-Specific Dynamic Behaviour During Type 2 Immune Responses

Correlation between circulating innate lymphoid cell precursors and thymic function

Perinatal thymic-derived CD8αβ-expressing γδ T cells are innate IFN-γ producers that expand in IL-7R–STAT5B-driven neoplasms

Sterile production of interferons in the thymus affects T cell repertoire selection

Ontogeny of thymic NK1.1+ cells.

Thymic iNKT single cell analyses unmask the common developmental program of mouse innate T cells

Specialized Tfh cell subsets driving type-1 and type-2 humoral responses in lymphoid tissue